Css LLC Roivant Sciences Ltd. Transaction History
Css LLC
- $830 Million
- Q1 2025
A detailed history of Css LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Css LLC holds 10,000 shares of ROIV stock, worth $112,000. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,000Holding current value
$112,000% of portfolio
0.01%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ROIV
# of Institutions
332Shares Held
496MCall Options Held
3.67MPut Options Held
754K-
Qvt Financial LP New York, NY65.8MShares$737 Million69.8% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X061.9MShares$693 Million5.69% of portfolio
-
Viking Global Investors LP46MShares$515 Million1.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.8MShares$457 Million0.01% of portfolio
-
Morgan Stanley New York, NY35.9MShares$402 Million0.03% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.89B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...